Detoxification and antioxidative therapy for levodopa-induced neurodegeneration in Parkinson's disease. - Wikidata - thesis-toulmin - TriplyDB

Detoxification and antioxidative therapy for levodopa-induced neurodegeneration in Parkinson's disease.

Detoxification and antioxidative therapy for levodopa-induced neurodegeneration in Parkinson's disease.

http://www.wikidata.org/entity/Q38112217

about

In vivo imaging of leucine aminopeptidase activity in drug-induced liver injury and liver cancer via a near-infrared fluorescent probe.Pharmacokinetic/pharmacodynamic evaluation of rasagiline mesylate for Parkinson's disease.The safety of istradefylline for the treatment of Parkinson's disease.Current and investigational non-dopaminergic agents for management of motor symptoms (including motor complications) in Parkinson's disease.Clinical drug research in chronic central neurodegenerative disorders.Nondopaminergic therapy of motor and nonmotor symptoms in Parkinson's disease: a clinician's perspective.Use of monoamine oxidase inhibitors in chronic neurodegeneration.Do we need a new levodopa?Levodopa/carbidopa intestinal gel (LCIG) infusion as mono- or combination therapy.ABCB1: is there a role in the drug treatment of Parkinson's disease?Levodopa, placebo and rotigotine change biomarker levels for oxidative stress.Levodopa increases oxidative stress and repulsive guidance molecule A levels: a pilot study in patients with Parkinson's disease.Levodopa-related cysteinyl-glycine and cysteine reduction with and without catechol-O-methyltransferase inhibition in Parkinson's disease patients.

P2860

Q33640221-E2270D7C-785F-44AE-A74A-7C55530DFABE Q38246682-3B04FFA2-AA75-4D16-ADB5-6B2F3867253C Q38353204-158EE3D1-AA85-4019-8BD4-67553539EC99 Q38636630-A57E2009-9CC5-49E9-BB37-71364A7D60A2 Q38763831-A80B7BBC-AF7A-4649-8351-FBA2B1B77C87 Q38947507-D17B1BA7-638F-4118-9FA7-B366A9A6BD07 Q39044780-A2133116-378D-4861-A339-E3645EC9BC25 Q42043001-B418C6DA-601E-40DD-B01F-D74AC4B01A99 Q47962428-6322966A-1D3F-4111-9416-7FA8AA6BF66A Q49968346-3A4180D2-8E19-41D2-AAEA-FC565857D09D Q50880421-F3B14A07-98AB-438C-8539-D265545FB3C1 Q52855994-056AA9EC-6EE5-4878-80D4-D81902B7E821 Q52880488-D2104074-99D3-4AAA-B8A5-9E73A682E247

P2860

Detoxification and antioxidative therapy for levodopa-induced neurodegeneration in Parkinson's disease.

http://www.wikidata.org/entity/Q38112217

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Detoxification and antioxidati ...... ration in Parkinson's disease.

@en

type

label

Detoxification and antioxidati ...... ration in Parkinson's disease.

@en

prefLabel

Detoxification and antioxidati ...... ration in Parkinson's disease.

@en

P1433

Q38112217-B10D7A50-11D8-4EC8-8299-8C1FA9160AFB

P1476

Q38112217-FA9EE789-5718-44D4-A59D-8A98E6D0B90B

P2860

Q38112217-0159C5F6-51CD-44C5-BF3D-26D0715089C5

Q38112217-0233BEE5-366F-4D9A-AD1C-36D5CEAFC43B

Q38112217-10A9E7C1-5270-4D7A-9B9B-8AD2D37B1C66

Q38112217-13B54ABA-CA65-4152-9449-5D1C70B2A74A

Q38112217-1B7F4599-0615-42D3-87EE-B1618A0F1EC0

Q38112217-1CB49986-9693-4E04-A87C-254E87E46F76

Q38112217-1E66BB8C-6883-4A50-9220-BDA61AEBC01E

Q38112217-1F308548-B2D6-43A7-9E4C-7C589B6E1E85

Q38112217-21267CF0-A040-49AB-B844-12DC3AAA96BB

Q38112217-22A92026-3457-4778-882F-8D80A076452F

P304

Q38112217-517D2563-D01D-46FB-911C-703A69894707

P31

Q38112217-5FBBB905-A8FD-41A8-8BC1-5DD98E6AD209

P356

Q38112217-7F8A7C9E-6818-45EA-A530-18032EE33FBA

P433

Q38112217-00F3C785-D7E2-4359-A826-6A3E8E0A7B01

P478

Q38112217-DF681A8E-B261-4ACD-8D73-1EA72561BA21

P50

Q38112217-E3410AFF-F822-44AE-8907-E1CE4E9D43A9

P577

Q38112217-A27D982C-D860-4BE2-A7AF-CB274ED98975

P698

Q38112217-043F699B-CC7E-4BBF-A321-8A0F60374371

P921

Q38112217-E5121176-B266-4962-8C58-BC15E4FAC595

P356

P1433

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

P1476

Detoxification and antioxidati ...... ration in Parkinson's disease.

@en

P2860

Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples

Occupation and risk of parkinsonism: a multicenter case-control study

Disturbance of iron metabolism in Parkinson's disease -- ultrasonography as a biomarker.

Iron metabolism in Parkinsonian syndromes.

Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine.

Paraquat induces oxidative stress, neuronal loss in substantia nigra region and parkinsonism in adult rats: neuroprotection and amelioration of symptoms by water-soluble formulation of coenzyme Q10

Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology?

Environmental neurotoxic pesticide increases histone acetylation to promote apoptosis in dopaminergic neuronal cells: relevance to epigenetic mechanisms of neurodegeneration

The neurotoxicity of DOPAL: behavioral and stereological evidence for its role in Parkinson disease pathogenesis.

Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease.

P304

707-718

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERN.13.50

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23739007

http://www.w3.org/2001/XMLSchema#string

P921